6505--Bupropion Tablets
ID: 36E79724R0029Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/325ffff29c614f4e92d913c89088eba2/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.

    Point(s) of Contact
    Andrew J CazaresContract Specialist
    Andrew.Cazares@va.gov
    Files
    Title
    Posted
    36E79724R0029_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) numbered 36E79724R0029 for the procurement of Bupropion Hydrochloride (HCL) Tablets. This procurement ensures a consistent supply of these medications for various federal institutions, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract will last one year with an option for four additional years. Offerors must provide unique product labels and National Drug Code (NDC) numbers for the items supplied. Expected annual usage indicates a need for over 158,000 bottles of Bupropion tablets in different dosages. The proposal’s electronic solicitation is scheduled for release around September 16, 2024, with a submission deadline of September 30, 2024. Interested participants must regularly check the SAM.gov website for updates, as no paper copies will be distributed. Andrew Cazares serves as the primary point of contact for inquiries related to this procurement process. The notice emphasizes the VA's commitment to uninterrupted access to necessary pharmaceuticals for veterans and other eligible entities.
    36E79724R0029.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for the procurement of Bupropion Hydrochloride tablets to serve veterans and related entities through the Pharmaceutical Prime Vendor (PPV) Programs. It specifies the required quantities for both the base year and four option years. Offerors must submit prices that include a 0.5% Cost Recovery Fee, alongside unique National Drug Code (NDC) numbers specific to their products. The solicitation details necessary compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products comply with FDA regulations and Good Manufacturing Practices (cGMP). The document also emphasizes the need for offerors to provide Letters of Commitment from manufacturers if they are not the producers, as well as demonstrating compliance with Federal Acquisition Regulation (FAR) requirements related to contract submissions. Additionally, the structure includes sections on contract clauses, requirements for manufacturing facilities, product registration, packaging, and barcode labeling. This solicitation reflects the VA's commitment to ensuring reliable and compliant pharmaceutical supply for its healthcare facilities while promoting participation from small and disadvantaged businesses.
    Lifecycle
    Title
    Type
    6505--Bupropion Tablets
    Currently viewing
    Solicitation
    6505--Bupropion Tablets
    Presolicitation
    Similar Opportunities
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0027, aimed at procuring Norethindrone Acetate Tablets (5mg) for various federal entities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and State Veterans Homes (SVH). The successful offeror will be required to provide an uninterrupted supply of the tablets, with a contract period of one year and four optional renewal years, and must adhere to specific labeling and packaging standards, including a unique NDC number and safety-cap design. This procurement is critical for ensuring the availability of essential medication for veterans and other federal health care facilities, with an estimated annual requirement of 13,202 bottles, each containing 50 tablets. Interested parties should submit their proposals by November 1, 2023, following the electronic release of the solicitation on or about October 18, 2023, and can direct inquiries to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    762-24-3-040-2385 -Tucson CMOP ACAMPROSATE -(VA-24-00083915)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking offers for the procurement of Acamprosate 333mg EC tablets under solicitation number 36C77024Q0392, aimed at fulfilling its pharmaceutical needs. Vendors are required to submit a comprehensive proposal that includes pricing schedules, valid state licenses, and compliance certifications, with a focus on maintaining high standards for drug quality and adherence to regulatory requirements. This procurement is crucial for ensuring the availability of essential medications for veterans, reflecting the government's commitment to supporting small businesses through a total small business set-aside. Interested vendors must submit their bids by September 17, 2024, at 4:00 PM CST, and can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.
    R702--PBM Drug Pricing Database [VA-25-00000408]
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a subscription service to access Pharmacy Average Wholesale Pricing (AWP) data, aimed at ensuring compliance with federal regulations regarding pharmacy agreements with third-party payers and pharmacy benefit managers. This service is critical for the VA to assess whether reimbursement rates proposed by PBMs meet federal requirements, thereby maximizing revenue streams while adhering to legal standards. The contract is set for one year, starting in December 2024, with an option for four additional years, and has an estimated budget of approximately $19.5 million. Interested vendors must submit their proposals by October 1, 2024, and can contact Contract Specialist Orangella Bittick at Orangella.Bittick@va.gov or (314) 894-6460 for further information.
    6505--BUDESONIDE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Budesonide inhalation suspension, specifically for the National CMOP Office in Tucson, Arizona. This solicitation is set aside for small businesses, requiring the delivery of 6,776 cartons of Budesonide 0.5MG/2ML inhalation suspension, with each carton containing 30 ampules formatted for single-dose use. The procurement is critical for ensuring the availability of high-quality pharmaceutical supplies for veterans, adhering to strict compliance and safety standards, including the Drug Supply Chain Security Act. Interested vendors must submit their proposals by September 18, 2024, at 10 AM CDT, and can contact Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov for further information.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    SPE2D220R0063 BUPROPION XL AMENDMENT 0002
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking BUPROPION XL. This procurement is for drugs and biologicals under PSC code 6505. The primary contact for this procurement is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778) and the secondary contact is Denise Taubman (denise.taubman@dla.mil, 2157376877). The notice includes Amendment 0002, which incorporates telecommunication clauses. The solicitation is not reopened and the closing date is not extended. BUPROPION XL is typically used for medical purposes.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Levothyroxine Tablets under the solicitation titled '6505--Levothyroxine Tablets (VA-24-00084562)'. This procurement aims to acquire pharmaceutical preparations, specifically Levothyroxine, which is critical for treating thyroid hormone deficiencies in veterans. The contract will fall under the NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and the PSC code 6505, indicating Drugs and Biologicals. Interested vendors can reach out to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details regarding the submission process and deadlines.